Clinical Investigation to Validate the Safety and Performance of Integrating Functional Electrical Stimulation Into the
RecruitingNCT07550699Phase: NAStarted 2026-04-20
Summary
The primary objective of this study is to validate the safety and clinical performance of the ABLE Exoskeleton with integrated Functional Electrical Stimulation (ABLE FES) in individuals with neurolog
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
80 Years
Locations
therapy2people GmbHVienna, State of Vienna, Austria
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07550699